Jane Street’s Microbot Medical MBOT Stock Holding History

Jane Street’s Portfolio MBOT Stock Details MBOT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$25.5K	Buy	+10,600	New	+$23.7K	﹤0.01%	11147

Other funds holding MBOT

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

CBU

CIBC Bancorp USA Chicago, Illinois $74.4B AUM

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DnB Asset Management Oslo, Norway $28B AUM 26% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Jane Street's MBOT Position: Q1 2026 in Review

Jane Street reduced its Microbot Medical (MBOT) stake by 28% in Q1 2026, selling an estimated $125K and leaving 141,541 shares worth $341K. The position accounts for ﹤0.01% of the portfolio, ranked #8940.

Jane Street first reported a position in MBOT in Q1 2014 and has held it in 7 quarters since. The position peaked at $591K in Q3 2025. 79 funds tracked by Wall St. Rank hold MBOT as of Q1 2026.

Jane Street held 141,541 shares of Microbot Medical worth $341K as of Q1 2026.
Jane Street sold 55,867 Microbot Medical shares in Q1 2026, an estimated $125K.
Microbot Medical made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #8940 holding.
Jane Street first reported a position in Microbot Medical in Q1 2014 and has held it in 7 quarters since.
Jane Street's Microbot Medical position peaked at $591K in Q3 2025.
79 funds tracked by Wall St. Rank held Microbot Medical as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.